Retatrutide

179 $

Retatrutide (LY-3437943) is an investigational triple agonist drug developed by Eli Lilly for weight loss and metabolic health. It activates GLP-1, GIP, and glucagon receptors to improve insulin response, suppress appetite, and boost fat burning. In clinical trials, participants lost up to 24% body weight in 48 weeks with once-weekly injections. Currently in Phase-3 trials and not yet FDA-approved for public use.

SKU: N/A Category: Products Tags: buy retatrutide online, retatrutide 10mg where to buy, retatrutide where to buy, retatrutide where to buy usa, where can i buy retatrutide peptide, where to buy retatrutide

Retatrutide (LY-3437943) is a next-generation investigational drug developed by Eli Lilly for the treatment of obesity and metabolic disorders. It is a novel triple agonist that activates GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and Glucagon receptors simultaneously. This triple action helps optimize metabolism, control appetite, and enhance fat burning.

🔬 Mechanism of Action

Retatrutide works by mimicking GLP-1 and GIP to improve insulin secretion, regulate blood sugar, and reduce hunger, while glucagon receptor activation increases energy expenditure (fat breakdown). The combined effect results in significant and sustainable weight loss and improved overall metabolic health.

🧪 Clinical Research

In Phase-2 clinical trials, Retatrutide showed unprecedented results, with participants losing up to 24% of their body weight in 48 weeks at the highest 12 mg weekly dose. The drug has a half-life of approximately 6 days, which allows for a convenient once-weekly injection.